Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
15
pubmed:dateCreated
1983-9-9
pubmed:abstractText
We have determined the amino acid sequence of the Fv [variable heavy (VH) and variable light (VL)] region of a human monoclonal IgM-kappa with antibody activity against 3,4-pyruvylated galactose, isolated from the plasma of patient WEA with Waldenström macroglobulinemia. The VH region has 114 residues, belongs to subgroup III, and has a very short third complementarity-determining region (CDR3), probably due to a small D segment/or an unusual D-J rearrangement (D, diversity; J, joining). The VL region has 108 residues and belongs to subgroup V kappa I. Compared to other members of the human VHIII and V kappa I families, WEA Fv does not appear to have significant differences within the framework residues but has unique CDRs that might be responsible for the particular antibody activity. Another IgM-kappa (GAL), which has an as-yet-undetermined antibody activity, shares a striking homology in V kappa with WEA, including an identical CDR1.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-103004, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-111144, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-111245, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-13032067, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-26343, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-351613, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-402363, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-4215080, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-4215718, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-4530984, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-4543460, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-4569769, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-4803843, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-4984234, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-6101209, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-6158553, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-6171189, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-6265099, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-6276389, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-629377, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-6461003, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-6765983, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-6766532, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-6769593, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-6779204, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-6783961, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-6787590, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-6790217, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-6790219, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-6794615, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-6812060, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-6813744, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-7018693, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-7312051, http://linkedlifedata.com/resource/pubmed/commentcorrection/6410398-97670
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
80
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4837-41
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
1983
pubmed:articleTitle
Amino acid sequence of the Fv region of a human monoclonal IgM (protein WEA) with antibody activity against 3,4-pyruvylated galactose in Klebsiella polysaccharides K30 and K33.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.